Silicon carbide (SiC) power semiconductor is a power device, which is used to control the distribution of power in an electronics system. The wider band gap, high switching frequency, and high electric field strength of SiC power devices allow them to be operated at higher temperatures and volumes as compared to their silicon counterparts. the silicon carbide power devices market has witnessed significant growth, owing to increasing number of industrial sectors that require SiC power devices such as manufacturing, automotive, and energy & power sectors.

Singapore's Energy Market Authority manages the Singaporean oil and gas sector and regulates the domestic electricity and natural gas industries. The city-state's sophisticated downstream sector, strategic location, extensive infrastructure and low-risk operating environment allow it to flourish as a regional refining and petrochemicals hub. State-owned Pavilion Energy is responsible for the marketing, distribution and storage of natural gas in Singapore, including small-scale LNG and LNG bunkering.

Sixth smallest market in the CEE region. Per capita spending is well above regional average. Market will record a mid single-digit US dollar CAGR. Other medical devices and consumables have the largest market shares. Most requirements are imported, largely from other EU countries. Local production of basic items is strong but geared to exports. Comprehensive public health insurance system. Relatively robust private health insurance sector. Slovenia has long had a good reputation in specialist areas such as dentistry, attracting patients from neighbouring countries.

One of the largest markets in the Middle East & Africa (MEA) region, similar in size to Iran. Market size is supported by a large population and Africa's most industrialised economy. Owing to the size of the population, per capita spending is low. Spending on medical devices as a proportion of wealth is below average for the MEA region. Other medical devices accounts for nearly 40% of the total market. Underdeveloped market offers considerable potential for growth but currently constrained by funding issues, poor infrastructure and staff shortages. National Health Insurance programme in the early stages of implementation, but question marks remain on funding and delivery of key targets. Limited medical device production, therefore market largely dependent on imports.

South Africa's pharmaceutical market is the single largest on the African continent. Its pharmaceutical spending per capita is high for an African country - at USD57 in 2017. We forecast South Africa's total pharmaceutical expenditure to increase from ZAR43.3bn (USD3.2bn) in 2017 to ZAR45.4bn (USD3.4bn) in 2018, equating to growth of 4.8% and 5.6% in local currency and US dollar terms respectively. Total pharmaceutical expenditure was equivalent to 0.9% of GDP and 11.1% of total healthcare expenditure in 2017. South Africa's pharmaceutical market is dominated by prescription drug spending, including patented and generic drug expenditure, which accounts for approximately 88.3% of the total market. OTC medicine spending represents the remainder of 11.5%. Of the three sub-divisions, patented medicines represent the largest single segment of the total market by value, at approximately 52.8% in 2017, followed by generic drug spending with 35.5% of total medicines spending.

South Africa's pharmaceutical market is the single largest on the African continent. Its pharmaceutical spending per capita is high for an African country - at USD57 in 2017. We forecast South Africa's total pharmaceutical expenditure to increase from ZAR43.3bn (USD3.2bn) in 2017 to ZAR45.4bn (USD3.4bn) in 2018, equating to growth of 4.8% and 5.6% in local currency and US dollar terms respectively. Total pharmaceutical expenditure was equivalent to 0.9% of GDP and 11.1% of total healthcare expenditure in 2017. South Africa's pharmaceutical market is dominated by prescription drug spending, including patented and generic drug expenditure, which accounts for approximately 88.3% of the total market. Over-the-counter (OTC) medicine spending represents the remainder of 11.5%. Of the three sub-divisions, patented medicines represent the largest single segment of the total market by value, at approximately 52.8% in 2017, followed by generic drug spending with 35.5% of total medicines spending.

South Korea's food industry is fairly well developed, producing traditional and modern food products. The industry is sophisticated and relies heavily on imports of raw materials, intermediate products, ingredients and additives. Other than rice and certain dairy products, in which it is self-sufficient, South Korea imports almost all types of agricultural products for processing. South Korean agriculture has long been plagued by the country's climatic and topographic unsuitability and accordant scarcity of agricultural land. In the past, government policy has also been viewed as impeding output growth, with tightly controlled limits in place on the ownership of agricultural land and tight restrictions on trade. However, faced with a growing food import bill, the government appears to be changing its stance.

In July, KOGAS and the Busan Port Corporation (BPC) signed an agreement to jointly study the feasibility of developing a floating LNG bunkering terminal, as part of a broader move to make LNG available as an alternative shipping fuel ahead of the IMO’s cap on sulphur content in global bunker fuels at 0.5% in 2020. KOGAS’ LNG sales rose 10.5% y-o-y in July to 2.36mn tonnes, with favourable policies and the temporary closure of several aging nuclear plants, driving stronger sales to both power generators and industrial end-users.

Ninth largest market in the Central & Eastern European (CEE) region. Lowest per capita spending in the CEE region. Market will record a high single-digit CAGR in local currency terms. Diagnostic imaging and other medical devices and have the largest market shares.  Most requirements are imported, largely from China, Germany and the US. The domestic production sector is weak and undercapitalised. Outdated and largely unreformed Soviet-era health system. Fighting in the eastern part of the country devastated the economy, but the outlook is improving.

The exploration and production of oil and gas is governed by a number of key legislations, namely: The Subsoil Code of Ukraine (the 'Subsoil Code'), 1994. The Law of Ukraine 'On Oil and Gas', 2001. The Law of Ukraine 'On Product Sharing Agreements', 1999. The Law of Ukraine 'On Basic Principles of the Natural Gas Market Functioning', 2010. Law of Ukraine 'On Amending Laws of Ukraine to Deregulate Oil and Gas Industry', 2018. Article 13 of Ukraine's constitution highlights that the Ukrainian National is the sole owner of the land and subsoil resources. However, the government can grant rights to use the subsoil and once the mineral is extracted, ownership can be transferred to the subsoil user.